---
title: "NU1433-10 RAR-M Therapeutics Ltd The Provision of Business Consultancy to Assist Commercialisation of University Research."
ocid: "ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "NEWCASTLE UNIVERSITY"
published: "2020-05-19"
---

# NU1433-10 RAR-M Therapeutics Ltd The Provision of Business Consultancy to Assist Commercialisation of University Research.

Buyer: NEWCASTLE UNIVERSITY  
Current stage: Award  
OCID: ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd.json)

## Summary

The procurement process titled "NU1433-10 RAR-M Therapeutics Ltd The Provision of Business Consultancy to Assist Commercialisation of University Research" is being conducted by Newcastle University in the United Kingdom. This contract, classified under business and management consultancy services, has a value of £30,000 and is currently in the awarded stage. The contract period begins on 1st May 2020 and concludes on 31st December 2020. The tender was initially due to close on 14th April 2020.

This tender presents significant growth opportunities for small and medium-sized enterprises (SMEs) with expertise in business consultancy, particularly those with experience in the pharmaceutical or biotechnology sectors. Companies that have a track record in commercialising research and developing market-leading drugs for neurodegenerative diseases would be particularly well-suited to compete. The opportunity to support Newcastle University's initiative could lead to further collaborations and investments in this evolving healthcare field.

## Notice

Amyotrophic lateral sclerosis (ALS) - as with most other neurodegenerative diseases, including Alzheimer's and Parkinson's - is a major medical challenge and is having an ever-increasing impact upon the lives of patients, carers and indeed of society as a whole. Scientists at Durham (Chemistry Department) and Aberdeen Universities have recently designed, synthesised and identified a lead drug candidate with the potential for establishing a new treatment approach for ALS and with a longer-term potential of being effective for other neurodegenerative diseases. The technology is now being patented and we are ready to develop a commercial vehicle to drive the drug development programme forwards and raise the necessary investment required for the next stages. The need for an experienced Business Executive/CEO, who has already delivered drugs to the market in the neurodegenerative area, is essential to support the Commercial Team and especially the CEO directly. Although two of the Team have commercial (spinout) experience (e.g. as CTO of LightOx who are successfully raising second phase major investment currently for LightOx), the successful launch of market leading drugs and the raising of the finance to make that happen is needed to successfully take the company forward. In the longer term (such as Phase III raise of ca. PS100+ million), such an executive might well be appointed as CEO, but in these early development stages, advise and business support is required

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/910dc1b3-d759-4de4-8eb8-0f9775e29dcc |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Not Specified |
| Procurement method details | Other - |
| Tender suitability | SME |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 19 May 2020 |
| Submission deadline | 14 Apr 2020 |
| Future notice date | Not specified |
| Award date | 21 Apr 2020 |
| Contract period | 30 Apr 2020 - 31 Dec 2020 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £30,000 |
| Lots value | Not specified |
| Awards value | £30,000 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NEWCASTLE UNIVERSITY |
| Locality | NEWCASTLE |
| Post town | Newcastle upon Tyne |
| Postcode | NE1 7RU |
| Country | England |
| ITL 1 | TLC North East (England) |
| ITL 2 | TLC4 Northumberland, Durham and Tyne & Wear |
| ITL 3 | TLC43 Tyneside |
| Local authority | Newcastle upon Tyne |
| Electoral ward | Monument |
| Westminster constituency | Newcastle upon Tyne Central and West |
| Delivery location | TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England) |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | DYODELTA BIOSCIENCES |

## CPV Codes

### Divisions

- 79 - Business services: law, marketing, consulting, recruitment, printing and security

### Codes

- 79400000 - Business and management consultancy and related services

## Release History

- 19 May 2020 at 09:28 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/910dc1b3-d759-4de4-8eb8-0f9775e29dcc

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/910dc1b3-d759-4de4-8eb8-0f9775e29dcc
  19th May 2020 - Awarded contract notice on Contracts Finder

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-3ba029fa-773a-4d18-8bfe-37f9fa03f5cd.json.